Open AccessThe dose-dependent antiangiogenic potential of apixaban: an experimental outlook
Author(s) -
Özgür Akkaya,
Eyüp AYDOĞAN>
Publication year - 2022
Publication title -
acta medica alanya
Language(s) - English
Resource type - Journals
ISSN - 2587-0319
DOI - 10.30565/medalanya.1129978
Subject(s) - apixaban , pharmacology , medicine , bevacizumab , chorioallantoic membrane , angiogenesis , chemotherapy , atrial fibrillation , rivaroxaban , warfarin